AstraZeneca (AZN) vs Eli Lilly (LLY)
AstraZeneca (AZN) and Eli Lilly (LLY) side by side: both in Healthcare, listed on London Stock Exchange and New York Stock Exchange. Eli Lilly is the larger of the two by approximate market capitalization (about 4.4×).
| Field | AstraZeneca | Eli Lilly |
|---|---|---|
| Legal name | AstraZeneca PLC | Eli Lilly and Company |
| Ticker | AZN | LLY |
| Exchange | London Stock Exchange XLON | New York Stock Exchange XNYS |
| Jurisdiction | United Kingdom | United States |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Market cap ≈ | $252.2bn | $1.1tn |
| Founded | 1999 | 1876 |
| Reporting currency | GBP | USD |
| LEI | PY6ZZQWO2IZFZC3IOL08 | FRDRIPF3EKNDJ2CQJL29 |
| ISIN | GB0009895292 | US5324571083 |
| FIGI | BBG001SCNW31 | BBG001S5STL8 |
| Index membership | FTSE 100 | S&P 500 |
| Held by (covered funds) | — | 1 |
AstraZeneca
Anglo-Swedish pharmaceutical company formed by the 1999 merger of Astra AB and Zeneca Group, with major franchises in oncology, cardiovascular and rare diseases. One of the largest companies on the London Stock Exchange.
Eli Lilly
Pharmaceutical maker; GLP-1 metabolic drugs (Mounjaro, Zepbound), oncology and neuroscience.
Market caps are computed from each issuer's own filed share count times the close on 2026-08-28, not copied from a vendor; LEI from GLEIF (CC0), ISIN read from each issuer's own primary listing document with its ISO 6166 check digit validated, FIGI from OpenFIGI, MIC from the ISO 10383 registry — full provenance on Sources. Not real-time, not investment advice. Both sides as data: /api/v1/companies/astrazeneca · /api/v1/companies/eli-lilly